Cargando…
O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer
SIMPLE SUMMARY: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glyc...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563872/ https://www.ncbi.nlm.nih.gov/pubmed/32878320 http://dx.doi.org/10.3390/cancers12092469 |
_version_ | 1783595585466531840 |
---|---|
author | Yokose, Takahiro Kabe, Yasuaki Matsuda, Atsushi Kitago, Minoru Matsuda, Sachiko Hirai, Miwa Nakagawa, Tomomi Masugi, Yohei Hishiki, Takako Nakamura, Yuki Shinoda, Masahiro Yagi, Hiroshi Abe, Yuta Oshima, Go Hori, Shutaro Nakano, Yutaka Honda, Kazufumi Kashiro, Ayumi Morizane, Chigusa Nara, Satoshi Kikuchi, Shojiro Shibahara, Takahiko Itonaga, Makoto Ono, Masayuki Minegishi, Naoko Koshiba, Seizo Yamamoto, Masayuki Kuno, Atsushi Handa, Hiroshi Sakamoto, Michiie Suematsu, Makoto Kitagawa, Yuko |
author_facet | Yokose, Takahiro Kabe, Yasuaki Matsuda, Atsushi Kitago, Minoru Matsuda, Sachiko Hirai, Miwa Nakagawa, Tomomi Masugi, Yohei Hishiki, Takako Nakamura, Yuki Shinoda, Masahiro Yagi, Hiroshi Abe, Yuta Oshima, Go Hori, Shutaro Nakano, Yutaka Honda, Kazufumi Kashiro, Ayumi Morizane, Chigusa Nara, Satoshi Kikuchi, Shojiro Shibahara, Takahiko Itonaga, Makoto Ono, Masayuki Minegishi, Naoko Koshiba, Seizo Yamamoto, Masayuki Kuno, Atsushi Handa, Hiroshi Sakamoto, Michiie Suematsu, Makoto Kitagawa, Yuko |
author_sort | Yokose, Takahiro |
collection | PubMed |
description | SIMPLE SUMMARY: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glycomic profiling of extracellular vesicles (EVs) derived from serum using lectin microarray. The glyco-candidates of PC-specific EVs were quantified using a high-sensitive exosome-counting system, ExoCounter. An absolute quantification system for altered glycan-containing EVs elevated in PC serum was established. EVs recognized by O-glycan-binding lectins ABA or ACA were identified as candidate markers by lectin microarray. Quantitative analyses using ExoCounter revealed that the ABA- or ACA-positive EVs were significantly increased in the serum of PC patients. These specific EVs with O-glycans can act as potential biomarkers in a liquid biopsy for PC patients screening. ABSTRACT: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glycomic profiling of extracellular vesicles (EVs) derived from serum (two cohorts including 117 PC patients and 98 normal controls) using lectin microarray. The glyco-candidates of PC-specific EVs were quantified using a high-sensitive exosome-counting system, ExoCounter. An absolute quantification system for altered glycan-containing EVs elevated in PC serum was established. EVs recognized by O-glycan-binding lectins ABA or ACA were identified as candidate markers by lectin microarray. Quantitative analyses using ExoCounter revealed that the ABA- or ACA-positive EVs were significantly increased in the culture of PC cell lines or in the serum of PC patients including carbohydrate antigen 19-9 negative patients with high area under curve values. The elevated numbers of EVs in PC serum returned to normal levels after pancreatectomy. Histological examination confirmed that the tumors stained with ABA/ACA. These specific EVs with O-glycans recognized by ABA/ACA are elevated in PC sera and can act as potential biomarkers in a liquid biopsy for PC patients screening. |
format | Online Article Text |
id | pubmed-7563872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75638722020-10-27 O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer Yokose, Takahiro Kabe, Yasuaki Matsuda, Atsushi Kitago, Minoru Matsuda, Sachiko Hirai, Miwa Nakagawa, Tomomi Masugi, Yohei Hishiki, Takako Nakamura, Yuki Shinoda, Masahiro Yagi, Hiroshi Abe, Yuta Oshima, Go Hori, Shutaro Nakano, Yutaka Honda, Kazufumi Kashiro, Ayumi Morizane, Chigusa Nara, Satoshi Kikuchi, Shojiro Shibahara, Takahiko Itonaga, Makoto Ono, Masayuki Minegishi, Naoko Koshiba, Seizo Yamamoto, Masayuki Kuno, Atsushi Handa, Hiroshi Sakamoto, Michiie Suematsu, Makoto Kitagawa, Yuko Cancers (Basel) Article SIMPLE SUMMARY: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glycomic profiling of extracellular vesicles (EVs) derived from serum using lectin microarray. The glyco-candidates of PC-specific EVs were quantified using a high-sensitive exosome-counting system, ExoCounter. An absolute quantification system for altered glycan-containing EVs elevated in PC serum was established. EVs recognized by O-glycan-binding lectins ABA or ACA were identified as candidate markers by lectin microarray. Quantitative analyses using ExoCounter revealed that the ABA- or ACA-positive EVs were significantly increased in the serum of PC patients. These specific EVs with O-glycans can act as potential biomarkers in a liquid biopsy for PC patients screening. ABSTRACT: Pancreatic cancer (PC) is among the most lethal malignancies due to an often delayed and difficult initial diagnosis. Therefore, the development of a novel, early stage, diagnostic PC marker in liquid biopsies is of great significance. In this study, we analyzed the differential glycomic profiling of extracellular vesicles (EVs) derived from serum (two cohorts including 117 PC patients and 98 normal controls) using lectin microarray. The glyco-candidates of PC-specific EVs were quantified using a high-sensitive exosome-counting system, ExoCounter. An absolute quantification system for altered glycan-containing EVs elevated in PC serum was established. EVs recognized by O-glycan-binding lectins ABA or ACA were identified as candidate markers by lectin microarray. Quantitative analyses using ExoCounter revealed that the ABA- or ACA-positive EVs were significantly increased in the culture of PC cell lines or in the serum of PC patients including carbohydrate antigen 19-9 negative patients with high area under curve values. The elevated numbers of EVs in PC serum returned to normal levels after pancreatectomy. Histological examination confirmed that the tumors stained with ABA/ACA. These specific EVs with O-glycans recognized by ABA/ACA are elevated in PC sera and can act as potential biomarkers in a liquid biopsy for PC patients screening. MDPI 2020-08-31 /pmc/articles/PMC7563872/ /pubmed/32878320 http://dx.doi.org/10.3390/cancers12092469 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yokose, Takahiro Kabe, Yasuaki Matsuda, Atsushi Kitago, Minoru Matsuda, Sachiko Hirai, Miwa Nakagawa, Tomomi Masugi, Yohei Hishiki, Takako Nakamura, Yuki Shinoda, Masahiro Yagi, Hiroshi Abe, Yuta Oshima, Go Hori, Shutaro Nakano, Yutaka Honda, Kazufumi Kashiro, Ayumi Morizane, Chigusa Nara, Satoshi Kikuchi, Shojiro Shibahara, Takahiko Itonaga, Makoto Ono, Masayuki Minegishi, Naoko Koshiba, Seizo Yamamoto, Masayuki Kuno, Atsushi Handa, Hiroshi Sakamoto, Michiie Suematsu, Makoto Kitagawa, Yuko O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer |
title | O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer |
title_full | O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer |
title_fullStr | O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer |
title_full_unstemmed | O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer |
title_short | O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer |
title_sort | o-glycan-altered extracellular vesicles: a specific serum marker elevated in pancreatic cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563872/ https://www.ncbi.nlm.nih.gov/pubmed/32878320 http://dx.doi.org/10.3390/cancers12092469 |
work_keys_str_mv | AT yokosetakahiro oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT kabeyasuaki oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT matsudaatsushi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT kitagominoru oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT matsudasachiko oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT hiraimiwa oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT nakagawatomomi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT masugiyohei oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT hishikitakako oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT nakamurayuki oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT shinodamasahiro oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT yagihiroshi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT abeyuta oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT oshimago oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT horishutaro oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT nakanoyutaka oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT hondakazufumi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT kashiroayumi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT morizanechigusa oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT narasatoshi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT kikuchishojiro oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT shibaharatakahiko oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT itonagamakoto oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT onomasayuki oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT minegishinaoko oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT koshibaseizo oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT yamamotomasayuki oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT kunoatsushi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT handahiroshi oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT sakamotomichiie oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT suematsumakoto oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer AT kitagawayuko oglycanalteredextracellularvesiclesaspecificserummarkerelevatedinpancreaticcancer |